Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest

circ.ahajournals.org December 6, 2016

Acute administration of exenatide to comatose patients in the ICU after OHCA is feasible and safe. Exenatide did not reduce neuron-specific enolase levels and did not significantly improve a composite end point of death and poor neurological function after 180 days.

cardiac arrest glucose ICU mortality placebo study trial

Impacts of Initial ICU Driving Pressure on Outcomes in Acute Hypoxemic Respiratory Failure

Effects of Surgery on Hemodynamics and Postoperative Delirium in Stanford Type A Aortic Dissection

Implementing a Bedside Percutaneous Tracheostomy and Ultrasound Gastrostomy Team Reduces Length of Stay and Hospital Costs

Predictors of Weaning Failure in Ventilated ICU Patients

Image-Guided Management of COVID-19 Lung Disease

Kill as Few Patients as Possible

Extracorporeal Membrane Oxygenation for Adults

The Only EKG Book You’ll Ever Need

Hot Lights, Cold Steel: Life, Death and Sleepless Nights in a Surgeon’s First Years

Also Human: The Inner Lives of Doctors

Marino’s The ICU Book: eBook without Multimedia

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

Bedside Procedures in the ICU

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

Evidence-Based Critical Care: A Case Study Approach

Clinical Examination Skills in the Adult Critically Ill Patient

Severe Trauma and Sepsis: Organ Damage and Tissue Repair

Moderate and Deep Sedation in Clinical Practice

Basics of Mechanical Ventilation